Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D supplementation in depressive or bipolar disorder
2018-003313-17Phase 3Active
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cholecalciferol in major depressive disorder (MDD) and bipolar disorder (BD) (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoint: Change in MADRS at 12 weeks. Started Feb 2021; status: active.
02
Drugs
cholecalciferol
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on 2018-003313-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003313-17.